M, W., SS, R., MD, J., G, I., F, M., L, H., . . . K, R. (2025). Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma. Blood cancer journal, 15(1), 144. https://doi.org/10.1038/s41408-025-01338-1
Chicago Style (17th ed.) CitationM, Winkelmann, et al. "Optimization and Validation of the International Metabolic Prognostic Index for CD19 CAR-T in Large B-cell Lymphoma." Blood Cancer Journal 15, no. 1 (2025): 144. https://doi.org/10.1038/s41408-025-01338-1.
MLA (9th ed.) CitationM, Winkelmann, et al. "Optimization and Validation of the International Metabolic Prognostic Index for CD19 CAR-T in Large B-cell Lymphoma." Blood Cancer Journal, vol. 15, no. 1, 2025, p. 144, https://doi.org/10.1038/s41408-025-01338-1.